2024
Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum.
Steiger K, Herrin J, Swarna K, Davis E, McCoy R. Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum. Diabetes Care 2024, 47: 818-825. PMID: 38387066, PMCID: PMC11043221, DOI: 10.2337/dc23-1552.Peer-Reviewed Original ResearchResidents of remote areasRural-urban continuumHazard ratioLower-extremity complicationsHazard of myocardial infarctionMedicare Advantage beneficiariesRemote areasHazard of strokeOptumLabs Data WarehouseComplications of diabetesLower hazardMyocardial infarctionRetrospective cohort studyHeart failureDiabetic complicationsCohort studyResidents of small townsEnd-stage kidney diseaseSmall townsChronic complications of diabetesChronic diabetic complicationsResidentsDiabetesDisparitiesChronic complications
2023
1271-P: Associations of Combined Socioeconomic, Behavioral, and Metabolic Factors with Undiagnosed Diabetes and Prediabetes among Different Racial and Ethnic Groups
DING Q, LU Y, HERRIN J, ZHANG T, MARRERO D. 1271-P: Associations of Combined Socioeconomic, Behavioral, and Metabolic Factors with Undiagnosed Diabetes and Prediabetes among Different Racial and Ethnic Groups. Diabetes 2023, 72 DOI: 10.2337/db23-1271-p.Peer-Reviewed Original ResearchUndiagnosed diabetesRace/ethnicityMetabolic factorsPrediabetes riskHealthcare accessNutrition Examination SurveyShort sleep durationPoor diet qualityNon-Hispanic blacksHealthy young adultsNon-Hispanic whitesExamination SurveyDiabetes riskChronic conditionsNational HealthAlcohol consumersPrediabetesHigh riskSleep durationDiabetesCluster 3Old maleDiet qualityLogistic regressionYoung adults1358-P: Disparities in Acute and Chronic Complications of Diabetes in Rural U.S.
STEIGER K, HERRIN J, SWARNA K, MCCOY R. 1358-P: Disparities in Acute and Chronic Complications of Diabetes in Rural U.S. Diabetes 2023, 72 DOI: 10.2337/db23-1358-p.Peer-Reviewed Original ResearchChronic diabetes complicationsDiabetes complicationsKidney diseaseMyocardial infarctionGreater incidenceEnd-stage kidney diseaseIncidence of strokeRate of complicationsLower extremity ulcersDiabetes-related complicationsHealth care utilizationOptumLabs Data WarehouseMedicare Advantage beneficiariesChronic complicationsCharcot jointExtremity ulcersHeart failureSevere hypoglycemiaCare utilizationSevere hyperglycemiaAtrial fibrillationLower incidenceComplicationsHigh incidenceDiabetes65-OR: Differences in the Use of Diabetes Medications with Cardiorenal Benefits between Rural and Urban America
STEIGER K, SWARNA K, HERRIN J, MCCOY R. 65-OR: Differences in the Use of Diabetes Medications with Cardiorenal Benefits between Rural and Urban America. Diabetes 2023, 72 DOI: 10.2337/db23-65-or.Peer-Reviewed Original ResearchGLP-1 RAsType 2 diabetesDiabetes medicationsCardiorenal benefitsMedication useKidney diseaseNew glucose-lowering medicationsDiabetes medication useMultiple biopsychosocial factorsGlucose-lowering medicationsChronic kidney diseaseDiabetes-related complicationsLow-income patientsMedicare Advantage beneficiariesRenal benefitsGLP-1RAsHeart failureBlack patientsDiabetes outcomesSpecialty careVascular diseaseBiopsychosocial factorsPatientsDiabetesSGLT2iAll-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020
McCoy R, Herrin J, Galindo R, Sindhu Swarna K, Umpierrez G, Hill Golden S, O'Connor P. All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020. Diabetes Research And Clinical Practice 2023, 197: 110263. PMID: 36693542, PMCID: PMC10023431, DOI: 10.1016/j.diabres.2023.110263.Peer-Reviewed Original Research
2022
1157-P: Mortality among People with Diabetes Experiencing Hypoglycemic and Hyperglycemic Crises
MCCOY R, HERRIN J, SWARNA K, GALINDO R, UMPIERREZ G, GOLDEN S, O'CONNOR P. 1157-P: Mortality among People with Diabetes Experiencing Hypoglycemic and Hyperglycemic Crises. Diabetes 2022, 71 DOI: 10.2337/db22-1157-p.Peer-Reviewed Original ResearchSevere hypoglycemiaPreventable acute complicationEmergency department visitsRelevant patient characteristicsRisk of deathType 2 diabetesHigh-risk individualsType 1 diabetesNovo NordiskRace/ethnicityAdvisory PanelAcute complicationsCause mortalityHyperglycemic crisisPatient characteristicsDepartment visitsKidney diseaseRisk individualsMortality rateSubsequent mortalityHypoglycemiaDiabetesHyperglycemiaMortalityNational Institute898-P: Impact of Switching to a High-Deductible Health Plan on Patients’ Out-of-Pocket Expenditures for Glucose-Lowering Drugs
JIANG D, HERRIN J, VAN HOUTEN H, MCCOY R. 898-P: Impact of Switching to a High-Deductible Health Plan on Patients’ Out-of-Pocket Expenditures for Glucose-Lowering Drugs. Diabetes 2022, 71 DOI: 10.2337/db22-898-p.Peer-Reviewed Original ResearchHigh-deductible health plansGlucose-lowering drugsHDHP enrolleesOOP expensesHealth outcomesPocket expenditureHealth plansBurden of treatmentCostly health conditionsPoor health outcomesDeductible Health PlansGlycemic managementHigh-value careKidney diseaseDiabetes managementOOP costsValue careOOP expenditurePrescription drugsDiabetesHealth conditionsDirect costsDrugsEnrolleesHealth insurance
2007
Cost and Effects of Performance Feedback and Nurse Case Management for Medicare Beneficiaries with Diabetes A Randomized Controlled Trial
Herrin J, Cangialose CB, Nicewander D, Ballard DJ. Cost and Effects of Performance Feedback and Nurse Case Management for Medicare Beneficiaries with Diabetes A Randomized Controlled Trial. Population Health Management 2007, 10: 328-336. PMID: 18163861, DOI: 10.1089/dis.2007.106719.Peer-Reviewed Original ResearchConceptsNurse case managementDiabetes careCase management modelCase managementModel health maintenance organizationMedicare perspectiveNurse case management modelProcess of carePrimary care networkHealth maintenance organizationHealthTexas Provider NetworkClinical outcomesIntervention armResource nursesBaseline differencesMedicare beneficiariesMedical clinicsMaintenance organizationCare networkSimilar interventionsClinical qualityCareSignificant differencesDiabetesTrials